Profile data is unavailable for this security.
About the company
AnteoTech Limited is an Australia-based company engaged in providing solutions for the clean energy and life sciences markets using applied materials technology. The principal activities of the Company consist of development and commercialization of nanotechnologies with surface management applications. The Company’s lead product, Anteo X, provides significant improvement in anode performance and the Company partners with global suppliers in lithium-ion battery manufacturing. Its clean energy technology (CET) technologies improve the energy densities, cycle life and cost- effectiveness of lithium-ion batteries. The Company has two programs underway: Anteo X, its binder additive and the High Silicon Anode technology. The Life Sciences division services the point-of-care and in vitro diagnostics markets from global diagnostics companies to technology developers. Its AnteoBind provides advantages in bioconjugation to rapidly speed up testing procedures and improve accuracy.
- Revenue in AUD (TTM)514.89k
- Net income in AUD-8.88m
- Incorporated1995
- Employees40.00
- LocationAnteotech LtdBrisbane Technology ParkSE 4 26 Brandl StEIGHT MILE PLAINS 4113AustraliaAUS
- Phone+61 73219-0085
- Fax+61 73219-0553
- Websitehttps://www.anteotech.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Noxopharm Ltd | 2.41m | -3.58m | 29.22m | 1.00k | -- | 5.32 | -- | 12.14 | -0.0123 | -0.0123 | 0.0082 | 0.0188 | 0.2847 | -- | 0.5672 | -- | -42.31 | -43.24 | -48.67 | -52.58 | -- | -- | -148.64 | -170.07 | -- | -- | 0.00 | -- | -60.33 | -9.37 | 76.24 | -- | -- | -- |
| Prescient Therapeutics Ltd | 687.57k | -8.24m | 30.60m | 3.00 | -- | 1.69 | -- | 44.51 | -0.0102 | -0.0102 | 0.0009 | 0.0224 | 0.0284 | -- | 3.31 | -- | -33.97 | -28.85 | -37.31 | -30.66 | -- | -- | -1,198.14 | -2,096.39 | -- | -288.97 | 0.018 | -- | 49.77 | 56.99 | -17.61 | -- | -- | -- |
| Amplia Therapeutics Ltd | 4.44m | -4.50m | 32.24m | 1.00 | -- | 1.61 | -- | 7.27 | -0.0221 | -0.0221 | 0.0218 | 0.0561 | 0.2647 | -- | 2.05 | -- | -26.86 | -25.13 | -32.90 | -27.42 | -- | -- | -101.48 | -206.74 | -- | -- | 0.122 | -- | 286.42 | 144.81 | 27.86 | -- | -6.91 | -- |
| Rhythm Biosciences Ltd | 52.28k | -6.86m | 34.80m | -- | -- | 40.13 | -- | 665.71 | -0.0301 | -0.0301 | 0.0002 | 0.0035 | 0.0114 | 1.91 | 1.02 | -- | -148.83 | -134.13 | -199.13 | -168.97 | -4,946.29 | -1,807.84 | -13,115.47 | -9,433.23 | 1.58 | -1,750.40 | 0.1589 | -- | -77.10 | -18.01 | 16.56 | -- | -5.69 | -- |
| LBT Innovations Limited | 1.31m | -3.74m | 35.15m | 17.00 | -- | 18.86 | -- | 26.83 | -0.0032 | -0.0032 | 0.001 | 0.0011 | 0.1712 | 0.0959 | 2.52 | -- | -48.89 | -34.86 | -78.03 | -38.53 | 88.63 | -- | -285.50 | -513.87 | 2.56 | -12.08 | 0.5686 | -- | -39.04 | -14.71 | 83.40 | -- | -69.50 | -- |
| Cynata Therapeutics Ltd | 417.71k | -9.74m | 38.85m | 0.00 | -- | 5.35 | -- | 93.00 | -0.0543 | -0.0543 | 0.0023 | 0.0402 | 0.0305 | -- | 1.85 | -- | -71.18 | -39.49 | -81.37 | -42.96 | -- | -- | -2,332.89 | -515.32 | -- | -- | 0.00 | -- | 18.38 | 16.51 | 31.75 | -- | -- | -- |
| IDT Australia Limited | 14.12m | -5.41m | 42.98m | 156.00 | -- | 1.50 | -- | 3.04 | -0.0154 | -0.0154 | 0.0404 | 0.0667 | 0.4734 | 1.84 | 2.62 | -- | -18.15 | -9.77 | -22.59 | -11.61 | 80.11 | 84.61 | -38.33 | -23.12 | 1.12 | -50.05 | 0.1601 | -- | 100.81 | 3.09 | 36.30 | -- | -10.39 | -- |
| Tryptamine Therapeutics Ltd | -100.00bn | -100.00bn | 55.19m | -- | -- | 9.12 | -- | -- | -- | -- | -- | 0.0049 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.0342 | -- | -- | -- | -- | -- | -- | -- |
| Anteotech Ltd | 514.89k | -8.88m | 58.27m | 40.00 | -- | 9.38 | -- | 113.18 | -0.0039 | -0.0039 | 0.0002 | 0.0021 | 0.0699 | -- | 2.55 | -- | -120.47 | -75.24 | -159.35 | -84.74 | -- | -- | -1,724.74 | -1,444.66 | -- | -- | 0.3055 | -- | 26.85 | 27.93 | 29.82 | -- | 68.39 | -- |
| Neurotech International Ltd | 3.34m | -5.07m | 69.32m | -- | -- | 5.73 | -- | 20.78 | -0.0054 | -0.0054 | 0.0037 | 0.0117 | 0.3807 | 0.00 | 11.59 | -- | -57.86 | -134.56 | -63.92 | -163.66 | 100.00 | -- | -151.98 | -462.38 | 38.81 | -- | 0.00 | -- | 165.98 | 67.39 | 34.94 | -- | -- | -- |
| Actinogen Medical Ltd | 291.02k | -13.04m | 73.98m | -- | -- | 3.31 | -- | 254.22 | -0.0061 | -0.0061 | 0.0001 | 0.0072 | 0.0159 | -- | 0.0433 | -- | -71.44 | -48.56 | -78.20 | -51.97 | -- | -- | -4,482.26 | -5,188.44 | -- | -163.10 | 0.0159 | -- | -20.63 | 7.31 | -21.32 | -- | -- | -- |
| Percheron Therapeutics Ltd | 615.48k | -11.92m | 76.72m | 8.00 | -- | 7.13 | -- | 124.65 | -0.0135 | -0.0135 | 0.0007 | 0.0104 | 0.045 | -- | 0.2912 | -- | -87.09 | -75.92 | -122.82 | -89.91 | -- | -- | -1,936.57 | -4,028.81 | -- | -1,956.65 | 0.0042 | -- | 59.90 | 56.21 | -4.74 | -- | -- | -- |
